Olaratumab (IMC-3G3, LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRalpha) human monoclonal IgG1 antibody with antitumor activity[1].
Molecular Weight:
(147.12 kDa)
Purity:
98.52
CAS Number:
[1024603-93-7]
Target:
PDGFR
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted